Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

13,14-dehydroprostaglandin I2 methyl ester

Known as: 13,14-dehydroprostacyclin methyl ester, 13,14-dehydro PGI2 methyl ester, prost-5-en-13-yn-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, methyl ester, (5Z,9 alpha,11 alpha,15S)- 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
This study aimed to determine whether prostacyclin (PGI2) functions as an endothelium-derived contracting factor (EDCF) in young… Expand
  • table 1
1984
1984
The main aims of the research for new PGI2 analogues are to increase (1) the duration of action and/or (2) biological selectivity… Expand
1983
1983
Fluoroprostacyclin (10,10-difluoro-13,14-dehydroprostacyclin) a stable analogue of PGI2, induced an increase of contractile… Expand
1982
1982
1 Elevation of cyclic adenosine 3′,5′‐monophosphate (cyclic AMP) in elicited populations of rat peritoneal macrophages was used… Expand
1978
1978
The effects of a recently synthesized, stable prostacyclin (PGI2) analog, 13,14-dehydro-PGI2 methyl ester, and authentic PGI2 and… Expand
1977
1977
Microsomes from stomach fundus and blood vessels transform the endoperoxide, PGH2, into a newly discovered unstable substance… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1